MOLBIO vs GKSL: Stock Comparison
Head-to-head financial and trading comparison between Molbio Diagnostics Limited (MOLBIO) and Gujarat Kidney And Super Speciality Limited (GKSL) in the Cross-Sector Peers sector.
MOLBIO
NSE: MOLBIOGKSL
NSE: GKSLKey Metrics Comparison Table
| Metric | MOLBIO | GKSL | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,438.60 | ₹184.09 | — |
| 1-Year Price Return | +38.1% | +63.49% | GKSL (25.39% higher) |
| 52-Week High | ₹1,544.70 | ₹194.27 | — |
| 52-Week Low | ₹1,036.65 | ₹110.40 | — |
| 30-Day Annualized Volatility | 95.93% | 44.2% | GKSL (Steadier) |
| 30-Day Average Daily Volume | 3,210,458 | 2,108,623 | MOLBIO (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MOLBIO and GKSL, which stock gave better returns over the last year?
GKSL has outperformed MOLBIO over the past 12 months with a gain of 63.49% compared to 38.1%.
Which stock is less volatile: MOLBIO or GKSL?
GKSL demonstrated lower price volatility (44.2% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MOLBIO vs GKSL?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MOLBIO and GKSL direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.